PBH
Prestige Consumer Healthcare Inc.
Price Chart
Latest Quote
$45.46
-1.51 (-3.21%)
Current Price
| Previous Close | $46.97 |
| Open | $46.52 |
| Day High | $46.83 |
| Day Low | $45.23 |
| Volume | 716,288 |
Stock Information
| Shares Outstanding | 47.37M |
| Total Debt | $1.05B |
| Cash Equivalents | $63.87M |
| Revenue | $1.09B |
| Net Income | $190.30M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $2.15B |
| P/E Ratio | 11.63 |
| EPS (TTM) | $3.91 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $3.14B |
| Sales | $1.09B |
| Income | $190.30M |
| Book/sh | $39.89 |
| Cash/sh | $1.35 |
| Employees | 890 |
Financial Ratios
| Quick Ratio | 2.12 |
| Current Ratio | 3.57 |
| Debt/Eq | 55.39 |
| EPS Growth TTM | 7.60% |
Returns & Margins
| ROA | 5.61% |
| ROE | 10.22% |
| Gross Margin | 55.65% |
| Operating Margin | 26.81% |
| Profit Margin | 17.48% |
Ownership
| Insider Ownership | 1.41% |
| Institutional Ownership | 113.74% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 9.06 |
| PEG | 1.42 |
| P/S | 1.98 |
| P/B | 1.14 |
Analyst Data
| Recommendation | none |
| Target Price | $66.80 |
Technical Indicators
| SMA20 | $47.19 |
| SMA50 | $51.35 |
| SMA200 | $59.95 |
| RSI | 47.90 |
| ATR | 1.7668 |
| Shares Float | 46.76M |
| Short Float | 7.38% |
| Short Ratio | 2.97 |
| Volatility | 0.35 |
| Rel Volume | 1.01 |
Performance History
| Week | -4.94% |
| Month | -3.67% |
| Quarter | -25.46% |
| 6 Months | -27.05% |
| YTD | -25.74% |
| Year | -45.65% |
| 3 Years | -20.69% |
| 5 Years | -12.49% |
| 10 Years | -16.60% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $45.46 | 716,288 |
| 2026-06-18 | $46.97 | 1,270,300 |
| 2026-06-17 | $46.14 | 939,100 |
| 2026-06-16 | $47.50 | 642,100 |
| 2026-06-15 | $46.67 | 726,100 |
| 2026-06-12 | $47.82 | 543,200 |
| 2026-06-11 | $47.57 | 571,000 |
| 2026-06-10 | $49.13 | 586,700 |
| 2026-06-09 | $48.66 | 772,600 |
| 2026-06-08 | $47.72 | 665,100 |
| 2026-06-05 | $47.18 | 507,400 |
| 2026-06-04 | $45.44 | 552,500 |
| 2026-06-03 | $45.44 | 619,700 |
| 2026-06-02 | $45.83 | 662,400 |
| 2026-06-01 | $45.95 | 820,800 |
| 2026-05-29 | $47.53 | 720,100 |
| 2026-05-28 | $48.47 | 486,200 |
| 2026-05-27 | $48.27 | 566,200 |
| 2026-05-26 | $48.02 | 933,100 |
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products in North America, Australia, and internationally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand; various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name; sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand; eye care products that provide relief from redness and itchiness under the Clear Eyes brand name; at-home removal of common and plantar warts under the Compound W brand; and ear wax removal products under the Debrox brand name. It also provides dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand; motion sickness relief products under the Dramamine brand; enemas and other laxative products under the Fleet brand name; stomach upset remedies under the Gaviscon brand; cough drops under the Luden's brand; products for yeast infections in women under the Monistat brand name; lice and parasite treatments under the Nix name; feminine care products, including washes, cloths, and sprays under the Summer's Eve brand; products for dry eyes under the TheraTears brand; nasal saline sprays and washes under the Fess brand name; and oral rehydration products under the Hydralyte brand. It sells its products to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
đ° Latest News
Does Earnings Miss, Weaker Outlook and Probe Into Disclosures Change The Bull Case For PBH?
Simply Wall St. âĸ 2026-06-14T04:14:08Z
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report?
Zacks âĸ 2026-06-12T15:30:05Z
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness
Insider Monkey âĸ 2026-06-02T14:10:54Z
Is the Options Market Predicting a Spike in Prestige Consumer Stock?
Zacks âĸ 2026-06-01T19:16:00Z
Prestige Consumer Healthcare Inc. Just Missed Earnings - But Analysts Have Updated Their Models
Simply Wall St. âĸ 2026-05-15T12:50:27Z
Prestige Consumer Healthcare Q4 Earnings Call Highlights
MarketBeat âĸ 2026-05-15T07:07:54Z
Prestige Consumer Healthcare Inc (PBH) Q4 2026 Earnings Call Highlights: Navigating Challenges ...
GuruFocus.com âĸ 2026-05-14T23:02:41ZSector Update: Healthcare Stocks Mixed Late Afternoon
MT Newswires âĸ 2026-05-14T19:48:58ZPrestige Consumer Healthcare Attributes Soft Results to Low Eye Care Sales, Weak Consumer Backdrop
MT Newswires âĸ 2026-05-14T17:44:27Z
Sector Update: Healthcare Stocks Softer Thursday Afternoon
MT Newswires âĸ 2026-05-14T17:43:33Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $482,794,000 | $494,416,000 | $492,786,000 | $494,883,000 |
| Cost Of Revenue | $493,127,000 | $503,299,000 | $500,909,000 | $502,431,000 |
| Total Revenue | $1,088,705,000 | $1,137,762,000 | $1,125,357,000 | $1,127,725,000 |
| Operating Revenue | $1,084,744,000 | $1,136,581,000 | $1,125,046,000 | $1,127,618,000 |
| Expenses | ||||
| Interest Expense | $42,339,000 | $47,632,000 | $67,160,000 | $69,164,000 |
| Total Expenses | $779,296,000 | $788,521,000 | $782,928,000 | $779,923,000 |
| Other Income Expense | $-9,574,000 | $-17,420,000 | $756,000 | $-372,553,000 |
| Other Non Operating Income Expenses | $-9,574,000 | $-4,954,000 | $756,000 | $-2,336,000 |
| Net Non Operating Interest Income Expense | $-42,339,000 | $-47,632,000 | $-67,160,000 | $-69,164,000 |
| Interest Expense Non Operating | $42,339,000 | $47,632,000 | $67,160,000 | $69,164,000 |
| Operating Expense | $286,169,000 | $285,222,000 | $282,019,000 | $277,492,000 |
| Selling And Marketing Expense | $148,782,000 | $155,723,000 | $153,315,000 | $145,061,000 |
| General And Administrative Expense | $116,447,000 | $108,209,000 | $106,152,000 | $107,354,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Net Interest Income | $-42,339,000 | $-47,632,000 | $-67,160,000 | $-69,164,000 |
| Normalized Income | $190,301,000 | $224,016,830 | $209,339,000 | $242,147,819 |
| Net Income From Continuing And Discontinued Operation | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Total Operating Income As Reported | $309,409,000 | $336,775,000 | $342,429,000 | $-22,415,000 |
| Net Income Common Stockholders | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Net Income | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Net Income Including Noncontrolling Interests | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Net Income Continuous Operations | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Pretax Income | $257,496,000 | $284,189,000 | $276,025,000 | $-93,915,000 |
| Special Income Charges | $0 | $-12,466,000 | $0 | $-370,217,000 |
| Operating Income | $309,409,000 | $349,241,000 | $342,429,000 | $347,802,000 |
| Depreciation Amortization Depletion Income Statement | $20,940,000 | $21,290,000 | $22,552,000 | $25,077,000 |
| Depreciation And Amortization In Income Statement | $20,940,000 | $21,290,000 | $22,552,000 | $25,077,000 |
| Gross Profit | $595,578,000 | $634,463,000 | $624,448,000 | $625,294,000 |
| Per Share | ||||
| Diluted EPS | $3.91 | $4.29 | $4.17 | $-1.65 |
| Basic EPS | $3.93 | $4.32 | $4.21 | $-1.65 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $-3,054,170 | $0 | $-45,763,181 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $331,108,000 | $374,460,000 | $373,860,000 | $378,091,000 |
| Total Unusual Items | $0 | $-12,466,000 | $0 | $-370,217,000 |
| Total Unusual Items Excluding Goodwill | $0 | $-12,466,000 | $0 | $-370,217,000 |
| Reconciled Depreciation | $31,273,000 | $30,173,000 | $30,675,000 | $32,625,000 |
| EBITDA (Bullshit earnings) | $331,108,000 | $361,994,000 | $373,860,000 | $7,874,000 |
| EBIT | $299,835,000 | $331,821,000 | $343,185,000 | $-24,751,000 |
| Diluted Average Shares | $48,720,000 | $50,080,000 | $50,178,000 | $49,889,000 |
| Basic Average Shares | $48,456,000 | $49,697,000 | $49,757,000 | $49,889,000 |
| Diluted NI Availto Com Stockholders | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Tax Provision | $67,195,000 | $69,584,000 | $66,686,000 | $-11,609,000 |
| Impairment Of Capital Assets | $0 | $12,466,000 | $0 | $370,217,000 |
| Selling General And Administration | $265,229,000 | $263,932,000 | $259,467,000 | $252,415,000 |
| Other Gand A | $116,447,000 | $108,209,000 | $106,152,000 | $107,354,000 |
| Other Special Charges | - | - | - | - |
| Gain On Sale Of Business | - | - | - | - |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-993,198,000 | $-987,878,000 | $-1,193,232,000 | $-1,422,362,000 |
| Total Assets | $3,494,313,000 | $3,402,218,000 | $3,318,417,000 | $3,353,729,000 |
| Total Non Current Assets | $3,062,829,000 | $2,953,890,000 | $2,943,374,000 | $2,961,986,000 |
| Other Non Current Assets | $10,870,000 | $3,273,000 | $5,725,000 | $3,005,000 |
| Goodwill And Other Intangible Assets | $2,880,714,000 | $2,822,775,000 | $2,848,316,000 | $2,869,446,000 |
| Other Intangible Assets | $2,299,605,000 | $2,295,350,000 | $2,320,583,000 | $2,341,893,000 |
| Current Assets | $431,484,000 | $448,328,000 | $375,043,000 | $391,743,000 |
| Other Current Assets | $16,564,000 | $8,442,000 | $13,082,000 | $4,117,000 |
| Inventory | $159,132,000 | $147,709,000 | $138,717,000 | $162,121,000 |
| Receivables | $191,920,000 | $194,293,000 | $176,775,000 | $167,016,000 |
| Receivables Adjustments Allowances | $-18,187,000 | $-16,314,000 | $-16,377,000 | $-20,205,000 |
| Other Receivables | $1,538,000 | $768,000 | $2,063,000 | $49,000 |
| Loans Receivable | $0 | $7,796,000 | $6,062,000 | $3,800,000 |
| Accounts Receivable | $208,569,000 | $202,043,000 | $185,027,000 | $183,372,000 |
| Cash Cash Equivalents And Short Term Investments | $63,868,000 | $97,884,000 | $46,469,000 | $58,489,000 |
| Cash And Cash Equivalents | $63,868,000 | $97,884,000 | $46,469,000 | $58,489,000 |
| Prepaid Assets | - | - | - | - |
| Allowance For Doubtful Accounts Receivable | - | - | - | - |
| Gross Accounts Receivable | - | - | - | - |
| Debt | ||||
| Net Debt | $933,071,000 | $894,473,000 | $1,079,335,000 | $1,287,299,000 |
| Total Debt | $1,045,428,000 | $1,044,250,000 | $1,139,656,000 | $1,367,091,000 |
| Long Term Debt And Capital Lease Obligation | $1,032,876,000 | $1,035,713,000 | $1,133,504,000 | $1,357,331,000 |
| Long Term Debt | $993,953,000 | $992,357,000 | $1,125,804,000 | $1,345,788,000 |
| Current Debt And Capital Lease Obligation | $12,552,000 | $8,537,000 | $6,152,000 | $9,760,000 |
| Current Debt | $2,986,000 | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $1,606,797,000 | $1,567,321,000 | $1,663,333,000 | $1,906,645,000 |
| Total Non Current Liabilities Net Minority Interest | $1,485,873,000 | $1,460,698,000 | $1,546,285,000 | $1,745,930,000 |
| Other Non Current Liabilities | $5,580,000 | $5,391,000 | $9,185,000 | $8,165,000 |
| Non Current Deferred Liabilities | $447,417,000 | $419,594,000 | $403,596,000 | $380,434,000 |
| Non Current Deferred Taxes Liabilities | $447,417,000 | $419,594,000 | $403,596,000 | $380,434,000 |
| Current Liabilities | $120,924,000 | $106,623,000 | $117,048,000 | $160,715,000 |
| Payables And Accrued Expenses | $96,245,000 | $83,881,000 | $98,675,000 | $136,663,000 |
| Interest Payable | $15,578,000 | $15,703,000 | $15,763,000 | $15,688,000 |
| Payables | $23,524,000 | $19,755,000 | $41,548,000 | $73,388,000 |
| Total Tax Payable | $733,000 | $830,000 | $2,569,000 | $10,645,000 |
| Income Tax Payable | $733,000 | $830,000 | $2,569,000 | $10,645,000 |
| Accounts Payable | $22,791,000 | $18,925,000 | $38,979,000 | $62,743,000 |
| Equity | ||||
| Common Stock Equity | $1,887,516,000 | $1,834,897,000 | $1,655,084,000 | $1,447,084,000 |
| Total Equity Gross Minority Interest | $1,887,516,000 | $1,834,897,000 | $1,655,084,000 | $1,447,084,000 |
| Stockholders Equity | $1,887,516,000 | $1,834,897,000 | $1,655,084,000 | $1,447,084,000 |
| Gains Losses Not Affecting Retained Earnings | $-28,368,000 | $-37,659,000 | $-34,495,000 | $-31,564,000 |
| Other Equity Adjustments | $-28,368,000 | $-37,659,000 | $-34,495,000 | $-31,564,000 |
| Retained Earnings | $1,746,103,000 | $1,555,802,000 | $1,341,197,000 | $1,131,858,000 |
| Other | ||||
| Treasury Shares Number | $8,892,000 | $6,501,000 | $5,680,000 | $5,165,000 |
| Ordinary Shares Number | $47,319,000 | $49,509,000 | $49,821,000 | $49,692,000 |
| Share Issued | $56,211,000 | $56,010,000 | $55,501,000 | $54,857,000 |
| Tangible Book Value | $-993,198,000 | $-987,878,000 | $-1,193,232,000 | $-1,422,362,000 |
| Invested Capital | $2,884,455,000 | $2,827,254,000 | $2,780,888,000 | $2,792,872,000 |
| Working Capital | $310,560,000 | $341,705,000 | $257,995,000 | $231,028,000 |
| Capital Lease Obligations | $48,489,000 | $51,893,000 | $13,852,000 | $21,303,000 |
| Total Capitalization | $2,881,469,000 | $2,827,254,000 | $2,780,888,000 | $2,792,872,000 |
| Treasury Stock | $439,301,000 | $277,208,000 | $219,621,000 | $189,114,000 |
| Additional Paid In Capital | $608,520,000 | $593,402,000 | $567,448,000 | $535,356,000 |
| Capital Stock | $562,000 | $560,000 | $555,000 | $548,000 |
| Common Stock | $562,000 | $560,000 | $555,000 | $548,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $38,923,000 | $43,356,000 | $7,700,000 | $11,543,000 |
| Current Capital Lease Obligation | $9,566,000 | $8,537,000 | $6,152,000 | $9,760,000 |
| Line Of Credit | $2,986,000 | - | - | - |
| Pensionand Other Post Retirement Benefit Plans Current | $12,127,000 | $14,205,000 | $12,221,000 | $14,292,000 |
| Current Accrued Expenses | $72,721,000 | $64,126,000 | $57,127,000 | $63,275,000 |
| Goodwill | $581,109,000 | $527,425,000 | $527,733,000 | $527,553,000 |
| Net PPE | $171,245,000 | $127,842,000 | $89,333,000 | $89,535,000 |
| Accumulated Depreciation | $-88,868,000 | $-81,235,000 | $-72,360,000 | $-66,995,000 |
| Gross PPE | $260,113,000 | $209,077,000 | $161,693,000 | $156,530,000 |
| Leases | $10,806,000 | $10,610,000 | $10,555,000 | $9,040,000 |
| Construction In Progress | $28,241,000 | $3,350,000 | $2,413,000 | $17,089,000 |
| Other Properties | $49,556,000 | $53,294,000 | $12,826,000 | $19,123,000 |
| Machinery Furniture Equipment | $120,515,000 | $109,920,000 | $104,340,000 | $80,281,000 |
| Buildings And Improvements | $48,859,000 | $31,353,000 | $31,009,000 | $30,447,000 |
| Land And Improvements | $2,136,000 | $550,000 | $550,000 | $550,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $134,200,000 | $118,267,000 | $118,871,000 | $141,267,000 |
| Work In Process | $2,079,000 | $2,880,000 | $636,000 | $220,000 |
| Raw Materials | $22,853,000 | $26,562,000 | $19,210,000 | $20,634,000 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $246,449,000 | $243,291,000 | $239,376,000 | $221,932,000 |
| Operating Activities | ||||
| Operating Cash Flow | $257,627,000 | $251,515,000 | $248,926,000 | $229,716,000 |
| Cash Flow From Continuing Operating Activities | $257,627,000 | $251,515,000 | $248,926,000 | $229,716,000 |
| Operating Gains Losses | $165,000 | $234,000 | $274,000 | $273,000 |
| Investing Activities | ||||
| Capital Expenditure | $-11,178,000 | $-8,224,000 | $-9,550,000 | $-7,784,000 |
| Investing Cash Flow | $-136,841,000 | $-17,452,000 | $-20,111,000 | $-11,584,000 |
| Cash Flow From Continuing Investing Activities | $-136,841,000 | $-17,452,000 | $-20,111,000 | $-11,584,000 |
| Net Other Investing Changes | $-1,927,000 | $-978,000 | - | $-3,800,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-156,283,000 | $-51,509,000 | $-25,000,000 | $-50,000,000 |
| Financing Cash Flow | $-156,062,000 | $-182,075,000 | $-241,015,000 | $-185,846,000 |
| Cash Flow From Continuing Financing Activities | $-156,062,000 | $-182,075,000 | $-241,015,000 | $-185,846,000 |
| Net Other Financing Charges | $-4,568,000 | $-5,832,000 | $-6,277,000 | $-5,466,000 |
| Net Common Stock Issuance | $-156,283,000 | $-51,509,000 | $-25,000,000 | $-50,000,000 |
| Other | ||||
| Repayment Of Debt | $-42,482,000 | $-139,536,000 | $-227,827,000 | $-157,752,000 |
| Issuance Of Debt | $42,986,000 | $0 | $0 | $20,000,000 |
| Interest Paid Supplemental Data | $43,843,000 | $47,804,000 | $63,248,000 | $54,243,000 |
| Income Tax Paid Supplemental Data | $45,944,000 | $52,117,000 | $59,637,000 | $40,739,000 |
| End Cash Position | $63,868,000 | $97,884,000 | $46,469,000 | $58,489,000 |
| Beginning Cash Position | $97,884,000 | $46,469,000 | $58,489,000 | $27,185,000 |
| Effect Of Exchange Rate Changes | $1,260,000 | $-573,000 | $180,000 | $-982,000 |
| Changes In Cash | $-35,276,000 | $51,988,000 | $-12,200,000 | $32,286,000 |
| Proceeds From Stock Option Exercised | $4,285,000 | $14,802,000 | $18,089,000 | $7,372,000 |
| Common Stock Payments | $-156,283,000 | $-51,509,000 | $-25,000,000 | $-50,000,000 |
| Net Issuance Payments Of Debt | $504,000 | $-139,536,000 | $-227,827,000 | $-137,752,000 |
| Net Short Term Debt Issuance | $2,986,000 | $0 | $0 | $0 |
| Short Term Debt Payments | $-40,000,000 | $0 | $0 | $-20,000,000 |
| Short Term Debt Issuance | $42,986,000 | $0 | $0 | $20,000,000 |
| Net Long Term Debt Issuance | $-2,482,000 | $-139,536,000 | $-227,827,000 | $-137,752,000 |
| Long Term Debt Payments | $-2,482,000 | $-139,536,000 | $-227,827,000 | $-157,752,000 |
| Net Business Purchase And Sale | $-123,736,000 | $-8,250,000 | $-10,561,000 | $-3,800,000 |
| Purchase Of Business | $-123,736,000 | $-8,250,000 | $-10,561,000 | $-3,800,000 |
| Net PPE Purchase And Sale | $-11,178,000 | $-8,224,000 | $-9,550,000 | $-7,784,000 |
| Purchase Of PPE | $-11,178,000 | $-8,224,000 | $-9,550,000 | $-7,784,000 |
| Change In Working Capital | $-17,623,000 | $-41,941,000 | $-39,831,000 | $-53,855,000 |
| Change In Other Working Capital | $32,000 | $-898,000 | $-1,412,000 | $-275,000 |
| Change In Other Current Liabilities | $-7,781,000 | $-7,630,000 | $-7,134,000 | $-6,687,000 |
| Change In Payables And Accrued Expense | $2,376,000 | $-12,427,000 | $-41,188,000 | $18,000,000 |
| Change In Accrued Expense | $2,527,000 | $6,984,000 | $-16,217,000 | $10,742,000 |
| Change In Payable | $-151,000 | $-19,411,000 | $-24,971,000 | $7,258,000 |
| Change In Account Payable | $-151,000 | $-19,411,000 | $-24,971,000 | $7,258,000 |
| Change In Prepaid Assets | $-6,968,000 | $4,655,000 | $-8,214,000 | $2,259,000 |
| Change In Inventory | $-1,597,000 | $-9,314,000 | $24,439,000 | $-42,225,000 |
| Change In Receivables | $-3,685,000 | $-16,327,000 | $-6,322,000 | $-24,927,000 |
| Changes In Account Receivables | $-3,685,000 | $-16,327,000 | $-6,322,000 | $-24,927,000 |
| Other Non Cash Items | $19,979,000 | $10,412,000 | $11,389,000 | $11,122,000 |
| Stock Based Compensation | $10,835,000 | $11,157,000 | $14,010,000 | $12,405,000 |
| Asset Impairment Charge | $0 | $12,466,000 | $0 | $370,217,000 |
| Deferred Tax | $22,697,000 | $14,409,000 | $23,070,000 | $-60,765,000 |
| Deferred Income Tax | $22,697,000 | $14,409,000 | $23,070,000 | $-60,765,000 |
| Depreciation Amortization Depletion | $31,273,000 | $30,173,000 | $30,675,000 | $32,625,000 |
| Depreciation And Amortization | $31,273,000 | $30,173,000 | $30,675,000 | $32,625,000 |
| Gain Loss On Sale Of PPE | $165,000 | $234,000 | $274,000 | $273,000 |
| Net Income From Continuing Operations | $190,301,000 | $214,605,000 | $209,339,000 | $-82,306,000 |
| Long Term Debt Issuance | - | $0 | $0 | $20,000,000 |
| Sale Of Business | - | - | - | - |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
| Gain Loss On Sale Of Business | - | - | - | - |
Fetched: 2026-06-20